Consistent with the lack of somatic mutations in cancer, background mutation rates comparable to olfactory receptor genes, and no patterns of copy number loss in cancer, neither PHLPP1 nor PHLPP2 qualifies as a tumor suppressor. The gene discussed is PHLPP1; the disease is neoplasm.